
Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK
Description
About Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK
The Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein Peptide (IEDB: 912070) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Nucleoprotein Peptide, H-GERQNATEIRASVGK-OH (Uniprot: B4URE0 aa: 17-31) from JPT is produced under strict quality control and quality management.
Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK - Specifications
- Peptide sequence: H-GERQNATEIRASVGK-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Influenza
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK
References:
Read References with JPT’s Antigen Peptides
Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK has been described in:
Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy., Proc Natl Acad Sci U S A, 2018 (PMID: 30541895)
Characterization of T cell receptors reactive to HCRT<sub>NH2</sub>, pHA<sub>273-287</sub>, and NP<sub>17-31</sub> in control and narcolepsy patients., Proc Natl Acad Sci U S A, 2022 (PMID: 35914171)
Documentation
Documentation for Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK
Properties
Properties of Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Influenza |
Layout: | Freeze-dried in glass vial |
Organism: | Influenza A |
Protein Name: | Nucleoprotein |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Influenza A (strain A/Russia:St.Petersburg/8/2006 H1N1) Nucleoprotein 17-31, GERQNATEIRASVGK
Information | Values |
---|---|
Sequence: | H-GERQNATEIRASVGK-OH |
Specifications: | 15mer peptide as TFA salt |